John Sprague
Director of Finance/CFO presso T2 BIOSYSTEMS, INC.
Patrimonio netto: 423 $ in data 31/03/2024
Profilo
John M.
Sprague's current job is as the Chief Financial Officer at T2 Biosystems, Inc. .
Mr. Sprague's former jobs include being the Chief Financial Officer at Xcellerex, Inc., a Senior Manager at Deloitte & Touche LLP from 1980 to 1992, the Chief Financial Officer at Caliber Imaging & Diagnostics, Inc. from 2017 to 2018, and a Finance Manager-North American Core Imaging at GE Healthcare, Inc. from 2011 to 2017.
Mr. Sprague obtained his undergraduate degree from the Wallace E Carroll School of Management in 1980.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
T2 BIOSYSTEMS, INC.
0.00% | 01/03/2024 | 141 ( 0.00% ) | 423 $ | 31/03/2024 |
Posizioni attive di John Sprague
Società | Posizione | Inizio |
---|---|---|
T2 BIOSYSTEMS, INC. | Director of Finance/CFO | 30/01/2018 |
Precedenti posizioni note di John Sprague
Società | Posizione | Fine |
---|---|---|
CALIBER IMAGING & DIAGNOSTICS, INC. | Director of Finance/CFO | 01/01/2018 |
GE Healthcare, Inc.
GE Healthcare, Inc. Medical SpecialtiesHealth Technology GE Healthcare, Inc. manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities that are used in medical imaging procedures. It offers dyes that are used in magnetic-resonance-imaging procedures. The firm also manufactures medical diagnostic equipment including CT image machines. It develops healthcare technological solutions for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceutical manufacturing. The company was founded in 1994 and is headquartered in Princeton, NJ. | Director of Finance/CFO | 01/01/2017 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1992 |
Xcellerex, Inc.
Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Xcellerex, Inc. manufactures and provides equipment to produce bio-molecules. Its products and services include FlexFactory, a bioprocess manufacturing platform that handles the production of bio-products, such as vaccines, yeast and insulins. The company was founded by Parrish M. Galliher in 2002 and was headquartered in Marlborough, MA. | Director of Finance/CFO | - |
Formazione di John Sprague
Wallace E Carroll School of Management | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
CALIBER IMAGING & DIAGNOSTICS, INC. | Health Technology |
T2 BIOSYSTEMS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Xcellerex, Inc.
Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Xcellerex, Inc. manufactures and provides equipment to produce bio-molecules. Its products and services include FlexFactory, a bioprocess manufacturing platform that handles the production of bio-products, such as vaccines, yeast and insulins. The company was founded by Parrish M. Galliher in 2002 and was headquartered in Marlborough, MA. | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
GE Healthcare, Inc.
GE Healthcare, Inc. Medical SpecialtiesHealth Technology GE Healthcare, Inc. manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities that are used in medical imaging procedures. It offers dyes that are used in magnetic-resonance-imaging procedures. The firm also manufactures medical diagnostic equipment including CT image machines. It develops healthcare technological solutions for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceutical manufacturing. The company was founded in 1994 and is headquartered in Princeton, NJ. | Health Technology |
- Borsa valori
- Insiders
- John Sprague